美国 · SEC FORM 4
Eton Pharmaceuticals, Inc.
ETON · Nasdaq · CIK 0001710340 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
43 同一窗口内观察到的 Form 4 交易行
29 sales · 14 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-06-10 · Opaleye Management Inc. · $125.5K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Krempa DavidChief Business Officer
○▼○▼○▼○○▼○▼
BRYNJELSEN SEANPresident & CEO
▼○○▼▼
Opaleye Management Inc.TenPercentOwner
▼▼▼▼▼
MAIER PAUL VDirector
○○▼▼
Adams Jennifer McKieDirector
○▼
● 买入▼ 卖出○ 其他
—
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-06-10 · Opaleye Management Inc..
近期 Form 4 活动
0买入
29卖出
24其他 Form 4 交易行
22SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出29 sale line(s) · 仅供背景
其他14 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,834,090
- 上期报告
- 1,542,982
- 日均成交量
- 624,706
- 回补天数
- 2.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-06-10 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 7,930 | USD 15.82 | USD 125,453 | SEC 申报 ↗ |
| 2024-10-23 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 10,000 | USD 7.98 | USD 79,800 | SEC 申报 ↗ |
| 2024-10-08 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 33,970 | USD 7.03 | USD 238,809 | SEC 申报 ↗ |
| 2024-10-07 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 11,248 | USD 7.22 | USD 81,211 | SEC 申报 ↗ |
| 2024-10-04 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 16,852 | USD 6.77 | USD 114,088 | SEC 申报 ↗ |
| 2024-09-11 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 50,000 | USD 4.75 | USD 237,500 | SEC 申报 ↗ |
| 2024-09-10 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 57,500 | USD 4.65 | USD 267,375 | SEC 申报 ↗ |
| 2022-09-22 | BRYNJELSEN SEAN | 买入 (P) | Common Stock | 10,000 | USD 2.10 | USD 21,000 | SEC 申报 ↗ |
| 2021-08-20 | Troutman William Wilson | 买入 (P) | Common Stock | 5,000 | USD 4.43 | USD 22,150 | SEC 申报 ↗ |
| 2021-08-20 | BRYNJELSEN SEAN | 买入 (P) | Common Stock | 10,000 | USD 4.32 | USD 43,200 | SEC 申报 ↗ |
| 2021-06-03 | BRYNJELSEN SEAN | 买入 (P) | Common Stock | 5,000 | USD 5.96 | USD 29,800 | SEC 申报 ↗ |
| 2020-10-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, par value $0.001 per share | 400,000 | USD 7.00 | USD 2,800,000 | SEC 申报 ↗ |
Form 4 申报证据
53 transaction lines in the latest 365-day window; 122 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Krempa David | 卖出 (S) | Common Stock | 4,166 | USD 55.07 | USD 229,406 | SEC 申报 ↗ |
| 2026-10-02 | Krempa David | 期权行权／转换 (M) | Common Stock | 10,522 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-28 | MAIER PAUL V | 卖出 (S) | Common Stock | 50,000 | USD 59.07 | USD 2,953,572 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Krempa David | 卖出 (S) | Common Stock | 4,166 | USD 55.07 | USD 229,406 | SEC 申报 ↗ |
| 2026-10-02 | Krempa David | 期权行权／转换 (M) | Common Stock | 10,522 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-28 | MAIER PAUL V | 卖出 (S) | Common Stock | 50,000 | USD 59.07 | USD 2,953,572 | SEC 申报 ↗ |
| 2026-08-28 | MAIER PAUL V | 期权行权／转换 (M) | Common Stock | 62,500 | USD 4.49 | USD 280,375 | SEC 申报 ↗ |
| 2026-08-28 | MAIER PAUL V | 卖出 (S) | Common Stock | 50,000 | USD 59.07 | USD 2,953,572 | SEC 申报 ↗ |
| 2026-08-28 | MAIER PAUL V | 期权行权／转换 (M) | Common Stock | 50,000 | USD 3.78 | USD 189,000 | SEC 申报 ↗ |
| 2026-08-24 | Krempa David | 卖出 (S) | Common Stock | 25,000 | USD 65.07 | USD 1,626,750 | SEC 申报 ↗ |
| 2026-08-24 | Krempa David | 期权行权／转换 (M) | Common Stock | 25,000 | USD 7.31 | USD 182,750 | SEC 申报 ↗ |
| 2026-08-20 | BRYNJELSEN SEAN | 卖出 (S) | Common Stock | 91,022 | USD 60.70 | USD 5,525,301 | SEC 申报 ↗ |
| 2026-08-19 | BRYNJELSEN SEAN | 卖出 (S) | Common Stock | 8,978 | USD 62.65 | USD 562,472 | SEC 申报 ↗ |
| 2026-07-14 | Opaleye Management Inc. | 卖出 (S) | Common Stock, par value $0.001 per share | 28,315 | USD 37.54 | USD 1,062,945 | SEC 申报 ↗ |
| 2026-07-14 | Opaleye Management Inc. | 卖出 (S) | Common Stock, par value $0.001 per share | 28,315 | USD 37.54 | USD 1,062,945 | SEC 申报 ↗ |
| 2026-07-14 | BRYNJELSEN SEAN | 期权行权／转换 (M) | Common Stock | 200,000 | USD 1.37 | USD 274,000 | SEC 申报 ↗ |
| 2026-07-12 | BRYNJELSEN SEAN | 期权行权／转换 (M) | Common Stock | 27,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-12 | Krempa David | 期权行权／转换 (M) | Common Stock | 10,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-07 | Opaleye Management Inc. | 卖出 (S) | Common Stock, par value $0.001 per share | 26,685 | USD 38.37 | USD 1,023,903 | SEC 申报 ↗ |
| 2026-07-06 | Opaleye Management Inc. | 卖出 (S) | Common Stock, par value $0.001 per share | 10,000 | USD 38.00 | USD 380,000 | SEC 申报 ↗ |
| 2026-07-02 | Opaleye Management Inc. | 卖出 (S) | Common Stock, par value $0.001 per share | 90,000 | USD 37.39 | USD 3,365,100 | SEC 申报 ↗ |
| 2026-06-17 | Adams Jennifer McKie | 卖出 (S) | Common Stock | 50,000 | USD 32.48 | USD 1,624,000 | SEC 申报 ↗ |
| 2026-06-17 | Adams Jennifer McKie | 期权行权／转换 (M) | Common Stock | 50,000 | USD 3.78 | USD 189,000 | SEC 申报 ↗ |
| 2026-05-28 | BRYNJELSEN SEAN | 卖出 (S) | Common Stock | 120,000 | USD 31.88 | USD 3,825,717 | SEC 申报 ↗ |
| 2026-05-27 | Krempa David | 卖出 (S) | Common Stock | 19,679 | USD 31.47 | USD 619,298 | SEC 申报 ↗ |
| 2026-05-27 | Krempa David | 期权行权／转换 (M) | Common Stock | 19,679 | USD 2.18 | USD 42,879 | SEC 申报 ↗ |
| 2026-05-26 | Krempa David | 卖出 (S) | Common Stock | 37,524 | USD 31.49 | USD 1,181,631 | SEC 申报 ↗ |
| 2026-05-26 | Krempa David | 期权行权／转换 (M) | Common Stock | 37,524 | USD 1.38 | USD 51,658 | SEC 申报 ↗ |
| 2026-05-22 | Krempa David | 卖出 (S) | Common Stock | 42,797 | USD 33.39 | USD 1,428,788 | SEC 申报 ↗ |
| 2026-05-22 | Krempa David | 期权行权／转换 (M) | Common Stock | 30,591 | USD 3.58 | USD 109,516 | SEC 申报 ↗ |
| 2026-04-21 | RIEDEL NORBERT G | 期权行权／转换 (M) | Common Stock | 32,155 | USD 8.10 | USD 260,605 | SEC 申报 ↗ |
| 2026-02-03 | RIEDEL NORBERT G | X (X) | Common Stock | 30,000 | USD 4.42 | USD 132,600 | SEC 申报 ↗ |
| 2026-01-14 | Krempa David | 代扣税 (F) | Common Stock | 1,942 | USD 15.62 | USD 30,334 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ETON |
| CIK | 0001710340 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 122 transaction lines from 2020-03-19 to 2026-10-06 19 P purchase lines · 75 S sale lines · 28 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.